Follow-up After Surgery for Testicular Cancer

Inclusion Criteria15

• Age ≥ 18 years.
• Histologically confirmed testicular cancer without distant metastasis and treated with curative intent less than 3 months ago:
• \. Non-seminomatous germ cell tumours, stage I low risk:
• No lymphadenopathy or metastases on the postoperative scan.
• Three consecutive blood drawings with normal tumour markers.
• Patients undergoing lymph node dissection as a second curative operation after an orchiectomy, can also be included in case that the postoperative scan shows no residual disease or metastases.
• \. Non-seminomatous germ cell tumours, stage I high risk:
• After completion of one cycle of Bleomycin, etoposide and platinum (BEP).
• Biochemical remission at completion of chemotherapy, meaning three consecutive blood drawings with normal tumour markers.
• No lymphadenopathy or metastases on the CT scan after completion of chemotherapy.
• \. Seminomatous or non-seminomatous germ cell tumours (after chemotherapy) with complete remission.
• Biochemical remission at completion of chemotherapy, meaning three consecutive blood drawings with normal tumour markers.
• No lymphadenopathy or metastases on the CT scan after completion of chemotherapy.
• Scheduled or currently undergoing postoperative surveillance according to national and European guidelines.
• Signed informed consent.